Thomas Singer
Hoffmann-La Roche
122 Papers
481 Citations
Thomas Singer is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: In vivo & Medicine. The author has an hindex of 29, co-authored 107 publications. Previous affiliations of Thomas Singer include Novartis & Ludwig Maximilian University of Munich.
Chat about Author
Papers
The safety and side effects of monoclonal antibodies
TL;DR: Some of the adverse effects encountered with mAb therapies are reviewed, and advances in preclinical testing and antibody technology aimed at minimizing the risk of these events are discussed.
NADH-quinone oxidoreductase: PSST subunit couples electron transfer from iron–sulfur cluster N2 to quinone
Franz Schuler,Takahiro Yano,S. Di Bernardo,Takao Yagi,V Yankovskaya,Thomas Singer,John E. Casida +6 more
TL;DR: It is established that the homologous PSST of mitochondria and NQO6 of bacteria have a conserved inhibitor-binding site and that this subunit plays a key role in electron transfer by functionally coupling iron-sulfur cluster N2 to quinone.
159
An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing: Support for a Proposal to Modify Current Regulatory Guidelines
Frank D. Sistare,Daniel Morton,Carl L. Alden,Joel Christensen,Douglas A. Keller,Sandra De Jonghe,Richard D. Storer,M. Vijayaraj Reddy,Andrew R. Kraynak,Bruce A. Trela,Jean-Guy Bienvenu,Sivert Bjurström,Vanessa Bosmans,David Brewster,Karyn Colman,Mark A. Dominick,John Evans,James R. Hailey,Lewis B. Kinter,Matt Liu,Charles R. Mahrt,Dirk Mariën,James R. Myer,Richard Perry,Daniel Potenta,Arthur Roth,Philip Sherratt,Thomas Singer,Rabih Slim,Keith A. Soper,Ronny Fransson-Steen,James H. Stoltz,Oliver C. Turner,Susan E. Turnquist,Marjolein van Heerden,Jochen Woicke,Joseph J. DeGeorge +36 more
TL;DR: A proposal to refine regulatory criteria for conducting a two-year rat study to be based on assessment of histopathologic findings from a rat six- month study, evidence of hormonal perturbation, genetic toxicology results, and the findings of a six-month transgenic mouse carcinogenicity study has the potential to eliminate over 40% of rat two- year testing on new pharmaceuticals without compromise to patient safety.
155
Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessment.
Martin Ebeling,Erich Küng,Angela See,Clemens Broger,Guido Steiner,Marco Berrera,Tobias Heckel,Leonardo Iniguez,Thomas J. Albert,Roland Schmucki,Hermann Biller,Thomas Singer,Ulrich Certa +12 more
TL;DR: The genome sequence of a long-tailed macaque female of Mauritian origin is determined using a whole-genome shotgun sequencing approach and allows high-resolution genotyping and microarray-based gene-expression profiling for animal stratification, thereby allowing the use of well-characterized animals for safety testing.
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy
Zhihua Li,Gary R. Mirams,Takashi Yoshinaga,Bradley J. Ridder,Xiaomei Han,Janell E. Chen,Norman Stockbridge,Todd Wisialowski,Bruce P. Damiano,Stefano Severi,Pierre Morissette,Peter R. Kowey,Mark Holbrook,Godfrey L. Smith,Randall L. Rasmusson,Michael Liu,Zhen Song,Zhilin Qu,Derek J. Leishman,Jill Steidl‐Nichols,Blanca Rodriguez,Alfonso Bueno-Orovio,Xin Zhou,Elisa Passini,Andrew G. Edwards,Stefano Morotti,Haibo Ni,Eleonora Grandi,Colleen E. Clancy,Jamie I. Vandenberg,Jamie I. Vandenberg,Adam P. Hill,Adam P. Hill,Mikiko Nakamura,Thomas Singer,Liudmila Polonchuk,Andrea Greiter-Wilke,Ken Wang,Stephane Nave,Aaron Fullerton,Eric A. Sobie,Michelangelo Paci,Flora Musuamba Tshinanu,David G. Strauss +43 more
TL;DR: This white paper presents principles for validating proarrhythmia risk prediction models for regulatory use as discussed at the In Silico Breakout Session of a Cardiac Safety Research Consortium/Health and Environmental Sciences Institute/US Food and Drug Administration–sponsored Think Tank Meeting on May 22, 2018.